Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 324

    1.

    Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.

    Schacker T, Hu HL, Koelle DM, Zeh J, Saltzman R, Boon R, Shaughnessy M, Barnum G, Corey L.

    Ann Intern Med. 1998 Jan 1;128(1):21-8.PMID: 9424977 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.

    Leone P, Warren T, Hamed K, Fife K, Wald A.

    Sex Transm Dis. 2007 Nov;34(11):900-7.PMID: 17538513 [PubMed - indexed for MEDLINE]Related articles

    3.

    Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

    Diaz-Mitoma F, Sibbald RG, Shafran SD, Boon R, Saltzman RL.

    JAMA. 1998 Sep 9;280(10):887-92.PMID: 9739972 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.

    Tyring SK, Diaz-Mitoma F, Shafran SD, Locke LA, Sacks SL, Young CL.

    J Cutan Med Surg. 2003 Nov-Dec;7(6):449-54.PMID: 15931690 [PubMed - indexed for MEDLINE]Related articles

    5.

    Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.

    Romanowski B, Aoki FY, Martel AY, Lavender EA, Parsons JE, Saltzman RL.

    AIDS. 2000 Jun 16;14(9):1211-7.PMID: 10894286 [PubMed - indexed for MEDLINE]Related articles

    7.

    Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.

    Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuñiga R, Magaret AS, Wald A, Corey L, Celum C.

    J Infect Dis. 2007 Nov 15;196(10):1500-8. Epub 2007 Oct 31.PMID: 18008230 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.

    Wald A, Selke S, Warren T, Aoki FY, Sacks S, Diaz-Mitoma F, Corey L.

    Sex Transm Dis. 2006 Sep;33(9):529-33.PMID: 16540883 [PubMed - indexed for MEDLINE]Related articles

    9.

    Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.

    Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran SD.

    JAMA. 1996 Jul 3;276(1):44-9.PMID: 8667538 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.

    Sperling RS, Fife KH, Warren TJ, Dix LP, Brennan CA.

    Sex Transm Dis. 2008 Mar;35(3):286-90.PMID: 18157071 [PubMed - indexed for MEDLINE]Related articles

    11.

    Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.

    Mertz GJ, Loveless MO, Levin MJ, Kraus SJ, Fowler SL, Goade D, Tyring SK.

    Arch Intern Med. 1997 Feb 10;157(3):343-9.PMID: 9040303 [PubMed - indexed for MEDLINE]Related articles

    12.

    Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.

    Wald A, Zeh J, Barnum G, Davis LG, Corey L.

    Ann Intern Med. 1996 Jan 1;124(1 Pt 1):8-15.PMID: 7503497 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men.

    Schacker T, Zeh J, Hu HL, Hill E, Corey L.

    J Infect Dis. 1998 Dec;178(6):1616-22.PMID: 9815213 [PubMed - indexed for MEDLINE]Related articles

    14.

    Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.

    Sacks SL, Aoki FY, Martel AY, Shafran SD, Lassonde M.

    Clin Infect Dis. 2005 Oct 15;41(8):1097-104. Epub 2005 Sep 12.PMID: 16163627 [PubMed - indexed for MEDLINE]Related articles

    15.

    Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing.

    Alster TS, Nanni CA.

    Dermatol Surg. 1999 Mar;25(3):242-6.PMID: 10193975 [PubMed - indexed for MEDLINE]Related articles

    16.

    Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

    Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T, Boon R, Saltzman R.

    Ann Intern Med. 1995 Jul 15;123(2):89-96.PMID: 7778840 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.

    Aoki FY, Tyring S, Diaz-Mitoma F, Gross G, Gao J, Hamed K.

    Clin Infect Dis. 2006 Jan 1;42(1):8-13. Epub 2005 Nov 23. Erratum in: Clin Infect Dis. 2006 Feb 15;42(4):588. PMID: 16323085 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.

    Fife KH, Warren TJ, Ferrera RD, Young DG, Justus SE, Heitman CK, Burroughs SM.

    Mayo Clin Proc. 2006 Oct;81(10):1321-7.PMID: 17036557 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

    Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L; HPTN 039 Protocol Team.

    Lancet. 2008 Jun 21;371(9630):2109-19.PMID: 18572080 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Famciclovir as antiviral prophylaxis in laser resurfacing procedures.

    Wall SH, Ramey SJ, Wall F.

    Plast Reconstr Surg. 1999 Sep;104(4):1103-8; discussion 1109.PMID: 10654754 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data